Liver stiffness in the hepatitis B virus carrier: A non-invasive marker of liver disease influenced by the pattern of transaminases

Table 2 Correlation between phase of infection, stage of liver disease and liver stiffness values

	n	Fibroscan values (kPa)
Blood donors	50	4.6 ± 1.2
Acute Hepatitis1	9	12.3 ± 3.3
Untreated HBsAg carriers overall1	188	8.9 ± 8.0
Inactive carriers whithout LD2	51	4.3 ± 1.0
Inactive carriers whit LD2	17	6.9 ± 2.3
CHB S0-S2	71	6.4 ± 2.4
CHB S3-S4	12	10.1 ± 3.8
CHB S5-S6	14	15.7 ± 9.0
US Cirrhosis3	23	23.6 ± 11.8
Treated CHB overall1	80	13.4 ± 9.7
CHB S0-S2	14	6.1 ± 1.7
CHB S3-S4	7	8.5 ± 2.8
CHB S5-S6	16	11.7 ± 5.2
US Cirrhosis3	43	17.2 ± 11.4

LD: Liver disease.

¹P < 0.001;

²P < 0.001;

³P = 0.035.